Related Experiment Video
Updated: Aug 7, 2026

14:45
Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
Published on: September 16, 2012
[Platelet phenotyping and study of alloantibodies using flow cytometry]
A Vergracht1, N Valentin, J D Bignon
1Laboratoire d'Immunologie leuco-plaquettaire, CRTS, Nantes.
Revue Francaise De Transfusion Et Immuno-Hematologie
|December 1, 1988
Summary
A new flow cytometry technique rapidly detects platelet alloantibodies and aids platelet grouping. This method is valuable for neonatal thrombocytopenia and post-transfusion purpura, unaffected by anti-HLA antibodies.
Area of Science:
- Immunology
- Hematology
- Biotechnology
Background:
- Platelet alloantibodies play a crucial role in transfusion reactions.
- Accurate detection and characterization are vital for patient management.
- Existing methods may have limitations in speed, sensitivity, or specificity.
Purpose of the Study:
- To introduce a novel flow cytometric technique for platelet alloantibody detection and platelet grouping.
- To establish a rapid, simple, sensitive, and specific method for clinical application.
Main Methods:
- A modified platelet suspension immunofluorescence test utilizing flow cytometry.
- Characterization of platelet alloantibodies and platelet grouping within the PLA system.
- Assessment of the technique's performance in the presence of anti-HLA antibodies.
Main Results:
- The developed flow cytometry technique is rapid, simple, sensitive, and specific.
- The method effectively detects and characterizes platelet alloantibodies.
- It is suitable for platelet grouping in the PLA system.
- Neonatal thrombocytopenia and post-transfusion purpura can benefit from this technique.
- Detection of anti-PLA1 antibodies is not hindered by the presence of anti-HLA antibodies.
Conclusions:
- This flow cytometric technique offers a significant advancement in platelet immunology.
- It provides a reliable tool for diagnosing and managing conditions related to platelet alloantibodies.
- The method's robustness, even with interfering antibodies, enhances its clinical utility.

